Infusional C-myb ASODN

C-myb antisense oligodeoxynucleotide · Abramson Cancer Center at Penn Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Infusional C-myb ASODN, covering 2016-09-26 to 2016-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Infusional C-myb ASODN in Advanced Hematologic Malignancies [Phase 1]